Minerva Neurosciences to Present at Jefferies 2017 Healthcare Conference on June 6, 2017
30 mai 2017 08h30 HE
|
Minerva Neurosciences, Inc.
WALTHAM, Mass., May 30, 2017 (GLOBE NEWSWIRE) -- Minerva Neurosciences, Inc. (NASDAQ:NERV), a clinical-stage biopharmaceutical company focused on the development of innovative therapies to treat...